Search by Drug Name or NDC

    NDC 00052-0602-02 TICE BCG 50 mg/50mL Details

    TICE BCG 50 mg/50mL

    TICE BCG is a INTRAVESICAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN.

    Product Information

    NDC 00052-0602
    Product ID 0052-0602_192772ac-a779-4cbb-a1ba-d69d84883736
    Associated GPIs 21700013001930
    GCN Sequence Number 048615
    GCN Sequence Number Description BCG live VIAL 50 MG INTRAVESIC
    HIC3 V1F
    HIC3 Description ANTINEOPLASTICS,MISCELLANEOUS
    GCN 14103
    HICL Sequence Number 033092
    HICL Sequence Number Description BCG LIVE
    Brand/Generic Generic
    Proprietary Name TICE BCG
    Proprietary Name Suffix n/a
    Non-Proprietary Name BACILLUS CALMETTE-GUERIN
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route INTRAVESICAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/50mL
    Substance Name BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Actively Acquired Immunity [PE], BCG Vaccine [CS], Increased Immunologically Active Molecule Activity [PE], Increased Macrophage Proliferation [PE], Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC], Live Attenuated Bacillus Calmette-Guerin Vac
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA102821
    Listing Certified Through 2024-12-31

    Package

    NDC 00052-0602-02 (00052060202)

    NDC Package Code 0052-0602-02
    Billing NDC 00052060202
    Package 1 VIAL in 1 CARTON (0052-0602-02) / 50 mL in 1 VIAL (0052-0602-01)
    Marketing Start Date 1990-08-24
    NDC Exclude Flag N
    Pricing Information N/A